Overview

Oral Vitamin C Administration on Erythropoietin Dosing Requirement in End-Stage Renal Disease Patients on Regular Hemodialysis

Status:
COMPLETED
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The study aimed to evaluate the safety and efficacy of oral vitamin C administration on erythropoietin dosing requirement in end-stage renal disease patients on regular hemodialysis.
Phase:
NA
Details
Lead Sponsor:
Ain Shams University
Treatments:
Ascorbic Acid